The fecal bacterial composition in the male WT and Nrf2 KO control groups was different from that in the male WT and Nrf2 KO AOM/DSS-treated groups, respectively (Figure 2C and Supplementary Figures S3A, B, E). The gene discussed is NFE2L2; the disease is infectious otitis media.